Stroke and cholesterol: weakness of risk versus strength of therapy.

Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/9730

Full metadata record

DC Field	Value	Language
dc.contributor.author	Donnan, Geoffrey A	en
dc.contributor.author	Davis, Stephen M	en
dc.date.accessioned	2015-05-15T22:55:51Z
dc.date.available	2015-05-15T22:55:51Z
dc.date.issued	2004-04-22	en
dc.identifier.citation	Stroke; A Journal of Cerebral Circulation 2004; 35(6): 1526	en
dc.identifier.govdoc	15105506	en
dc.identifier.other	PUBMED	en
dc.identifier.uri	https://ahro.austin.org.au/austinjspui/handle/1/9730	en
dc.language.iso	en	en
dc.subject.other	Cholesterol.blood	en
dc.subject.other	Humans	en
dc.subject.other	Hydroxymethylglutaryl-CoA Reductase Inhibitors.therapeutic use	en
dc.subject.other	Risk Factors	en
dc.subject.other	Stroke.epidemiology.prevention & control	en
dc.title	Stroke and cholesterol: weakness of risk versus strength of therapy.	en
dc.type	Journal Article	en
dc.identifier.journaltitle	Stroke	en
dc.identifier.affiliation	National Stroke Research Institute, Austin, and Repatriation Medical Centre and University of Melbourne, Australia	en
dc.identifier.doi	10.1161/01.STR.0000130461.47925.b0	en
dc.description.pages	1526	en
dc.relation.url	https://pubmed.ncbi.nlm.nih.gov/15105506	en
dc.type.austin	Journal Article	en
local.name.researcher	Donnan, Geoffrey A
item.grantfulltext	none	-
item.fulltext	No Fulltext	-
item.cerifentitytype	Publications	-
item.languageiso639-1	en	-
item.openairecristype	http://purl.org/coar/resource_type/c_18cf	-
item.openairetype	Journal Article	-
crisitem.author.dept	The Florey Institute of Neuroscience and Mental Health	-
Appears in Collections:	Journal articles

14

checked on Nov 30, 2024

Check